Onco Therapeutics
Publicou 4 edições por ano
ISSN Imprimir: 2694-4642
ISSN On-line: 2694-4650
Indexed in
Volume 2, 2011 Edição 1
DOI: 10.1615/ForumImmunDisTher.v2.i1
Held in los angeles, caliFornia, March 19−20, 2010
GUEST EDITORS:
BENJAMIN BONAVIDA, FAHD AL-MULLA, & KAM C. YEUNG
pp. iii-vi
DOI: 10.1615/ForumImmunDisTher.v2.i1.10
Phosphatidylenthanolamine Binding Protein aka Raf Kinase Inhibitor Protein: A Brief History of Its Discovery and the Remarkable Diversity of Biological Functions
pp. 1-12
DOI: 10.1615/ForumImmunDisTher.v2.i1.20
Raf Kinase Inhibitory Protein: A Signal Transduction Modulator and Metastasis Suppressor
pp. 13-20
DOI: 10.1615/ForumImmunDisTher.v2.i1.30
Inhibition of STAT3 Activation by RKIP in Colon Cancer
pp. 35-45
DOI: 10.1615/ForumImmunDisTher.v2.i1.50
Locostatin Disrupts Association of Raf Kinase Inhibitor Protein With Binding Proteins by Modifying a Conserved Histidine Residue in the Ligand-Binding Pocket
pp. 47-58
DOI: 10.1615/ForumImmunDisTher.v2.i1.60
Phosphotyrosine Recognition by the Raf Kinase Inhibitor Protein
pp. 59-70
DOI: 10.1615/ForumImmunDisTher.v2.i1.70
RKIP Enhances Angiotensin II - Stimulated Signaling
pp. 71-78
DOI: 10.1615/ForumImmunDisTher.v2.i1.80
RKIP-1 and the Cell Cycle: Novel Insight Into Genomic Instability
pp. 79-87
DOI: 10.1615/ForumImmunDisTher.v2.i1.90
Role of Raf Kinase Inhibitor Protein in Pathophysiology of Prostate Cancer
pp. 89-94
DOI: 10.1615/ForumImmunDisTher.v2.i1.100
Dual Roles of Raf-1 Kinase Inhibitor Protein in the Regulation of Both Tumor Cell Resistance to Apoptotic Stimuli and Epithelial to Mesenchymal Transition
pp. 95-109
DOI: 10.1615/ForumImmunDisTher.v2.i1.110
Última edição
Preface: Phytochemicals for Colorectal Cancer Therapy
Novel and Latest Computational and Development of Anticancer Cancer
Isoquinoline Alkaloids: Promising Natural Compounds for Targeting Angiogenesis and Metastasis in Colon Cancer
Naringenin in the Prevention of Colon Cancer: An Updated Review
Anti-Cancer Pectins and Their Role in Colorectal Cancer Treatment
Citrus Flavones Luteolin and Apigenin Target Fundamental Mechanisms in Colon Cancer
Dietary Phytocompounds for Colon Cancer Therapy
Nano-Formulation for Curcumin and Resveratrol in Colorectal Cancer Therapy